Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine adjunct to early antihypertensive therapy in intracerebral hemorrhage
IRCT20210530051440N2Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of morphine in intracerebral hemorrhage (ICH) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Blood pressure control. Started Dec 2022; status: completed.
02
Drugs
morphine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT20210530051440N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210530051440N2.